Industries de la santé
Novozymes acquires enzyme business from Canadian Iogen Corporation. The acquisition complements Novozymes’ existing business in the pulp & paper, textile, grain-processing and animal feed industries
31 Janvier 2013
Novozymes acquires Iogen Bio-Products, industrial enzyme business of Ottawa-based Iogen Corporation for CAD 67.5 million (approximately DKK 370 million) and potential earn-out payments of up to CAD 12.5 million (approximately DKK 70 million). The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities and know-how... |